Indivior Pharmaceuticals (INDV) Treasury Shares (2022 - 2026)

Indivior Pharmaceuticals' Treasury Shares history runs 5 years deep, the most recent figure standing at $4.0 million for Q1 2026.

• On a quarterly basis, Treasury Shares rose 62.87% year-over-year to $4.0 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a 62.87% increase from a year earlier, with the FY2025 full-year figure at $5.0 million, up 5.32% from the prior year.
• Treasury Shares slipped to $4.0 million in Q1 2026 per INDV's latest filing, from $5.0 million in the prior quarter.
• Across five years, Treasury Shares topped out at $5.5 million in Q2 2025 and bottomed at $1.2 million in Q4 2023.
• The 5-year median for Treasury Shares is $4.3 million (2024), against an average of $3.7 million.
• Across the five-year window, Treasury Shares decreased 24.95% in 2023 and jumped 304.2% in 2024, its largest moves.
• Year by year, Treasury Shares stood at $1.6 million in 2022, then retreated by 24.95% to $1.2 million in 2023, then soared by 304.2% to $4.7 million in 2024, then climbed by 5.32% to $5.0 million in 2025, then dropped by 20.01% to $4.0 million in 2026.
• Per Business Quant, the three latest INDV Treasury Shares figures stand at $4.0 million (Q1 2026), $5.0 million (Q4 2025), and $5.4 million (Q3 2025).